John H. Alexander

43.2k total citations · 4 hit papers
432 papers, 15.4k citations indexed

About

John H. Alexander is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, John H. Alexander has authored 432 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 315 papers in Cardiology and Cardiovascular Medicine, 106 papers in Surgery and 48 papers in Internal Medicine. Recurrent topics in John H. Alexander's work include Atrial Fibrillation Management and Outcomes (184 papers), Antiplatelet Therapy and Cardiovascular Diseases (93 papers) and Acute Myocardial Infarction Research (87 papers). John H. Alexander is often cited by papers focused on Atrial Fibrillation Management and Outcomes (184 papers), Antiplatelet Therapy and Cardiovascular Diseases (93 papers) and Acute Myocardial Infarction Research (87 papers). John H. Alexander collaborates with scholars based in United States, Sweden and Canada. John H. Alexander's co-authors include Renato D. Lópes, Lars Wallentin, Christopher B. Granger, Elaine M. Hylek, Ziad Hijazi, Robert A. Harrington, Michael G. Hanna, Daniel Wojdyla, Michael Hanna and Laine Thomas and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John H. Alexander

408 papers receiving 14.9k citations

Hit Papers

Effect of Linagliptin vs Placebo on Major Cardiov... 2012 2026 2016 2021 2018 2012 2016 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Alexander United States 70 10.7k 4.0k 3.3k 1.5k 1.4k 432 15.4k
Dan Atar Norway 57 10.0k 0.9× 2.5k 0.6× 1.6k 0.5× 1.5k 1.0× 815 0.6× 386 15.0k
Ran Kornowski Israel 56 10.2k 1.0× 7.6k 1.9× 1.4k 0.4× 2.0k 1.4× 471 0.3× 652 15.5k
Charles R. Bridges United States 38 6.1k 0.6× 3.5k 0.9× 757 0.2× 746 0.5× 537 0.4× 114 9.8k
Victor Aboyans France 45 7.5k 0.7× 8.8k 2.2× 1.8k 0.5× 1.3k 0.9× 1.5k 1.0× 266 16.5k
Felix Zijlstra Netherlands 67 14.7k 1.4× 9.9k 2.5× 1.3k 0.4× 1.0k 0.7× 1.2k 0.9× 566 19.4k
Neal S. Kleiman United States 74 16.4k 1.5× 10.4k 2.6× 3.6k 1.1× 2.3k 1.5× 445 0.3× 454 21.4k
Sabino Iliceto Italy 67 12.0k 1.1× 3.7k 0.9× 1.3k 0.4× 2.1k 1.4× 231 0.2× 521 16.2k
Iréne Lang Austria 74 12.3k 1.1× 3.3k 0.8× 3.3k 1.0× 2.2k 1.5× 515 0.4× 527 20.4k
Juan J. Badimón United States 70 8.7k 0.8× 8.3k 2.1× 1.8k 0.5× 1.8k 1.2× 2.6k 1.8× 305 21.3k
Marco Roffi Switzerland 45 12.1k 1.1× 6.5k 1.6× 1.0k 0.3× 1.6k 1.1× 440 0.3× 271 16.6k

Countries citing papers authored by John H. Alexander

Since Specialization
Citations

This map shows the geographic impact of John H. Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Alexander more than expected).

Fields of papers citing papers by John H. Alexander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Alexander. The network helps show where John H. Alexander may publish in the future.

Co-authorship network of co-authors of John H. Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Alexander. A scholar is included among the top collaborators of John H. Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Alexander. John H. Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fudim, Marat, Renato D. Lópes, Daniel Wojdyla, et al.. (2025). Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention. JACC Advances. 4(4). 101665–101665. 1 indexed citations
2.
Sandner, Sigrid, Björn Redfors, Kevin R. An, et al.. (2024). Coronary Artery Bypass Graft Failure in Women. Journal of the American College of Cardiology. 84(2). 182–191. 9 indexed citations
3.
Eikelboom, John W., Hardi Mundl, John H. Alexander, et al.. (2024). Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials. Journal of the American College of Cardiology. 83(6). 669–678. 4 indexed citations
4.
Carson, Jeffrey L., John H. Alexander, Paul C. Hébert, et al.. (2024). Effect of four hemoglobin transfusion threshold strategies in patients with acute myocardial infarction and anemia: a target trial emulation using MINT trial data. European Heart Journal. 45(Supplement_1). 2 indexed citations
5.
Wojdyla, Daniel, Alexander C. Fanaroff, Andrzej Budaj, et al.. (2024). Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI. Journal of the American College of Cardiology. 84(10). 875–885. 1 indexed citations
6.
Alexander, John H., et al.. (2023). Probabilistic error assessment and correction of design code-based shear strength prediction models for reliability analysis of prestressed concrete girders. Engineering Structures. 279. 115664–115664. 4 indexed citations
7.
Redfors, Björn, Gregg W. Stone, John H. Alexander, et al.. (2023). Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. Journal of the American College of Cardiology. 83(5). 549–558. 10 indexed citations
8.
Gaudino, Mario, Lamia Harik, Björn Redfors, et al.. (2023). The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery–Extended Follow-Up study (PALACS-EF): rationale and design. European Heart Journal Open. 3(6). oead118–oead118. 1 indexed citations
9.
Pol, Tymon, Ziad Hijazi, Johan Lindbäck, et al.. (2021). Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. Cardiovascular Research. 118(9). 2112–2123. 20 indexed citations
10.
Pol, Tymon, Ziad Hijazi, Johan Lindbäck, et al.. (2021). Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 8(1). e001471–e001471. 7 indexed citations
11.
Gaudino, Mario, Antonino Di Franco, Deepak L. Bhatt, et al.. (2021). The association between coronary graft patency and clinical status in patients with coronary artery disease. European Heart Journal. 42(14). 1433–1441. 38 indexed citations
12.
Hijazi, Ziad, Lars Wallentin, Johan Lindbäck, et al.. (2020). Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. Journal of the American Heart Association. 9(24). e018984–e018984. 41 indexed citations
13.
McGuire, Darren K., John H. Alexander, Odd Erik Johansen, et al.. (2019). Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 139(3). 351–361. 112 indexed citations
14.
Samad, Zainab, Linda K. Shaw, Matthew Phelan, et al.. (2015). Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. European Heart Journal. 36(40). 2733–2741. 43 indexed citations
15.
Avezum, Álvaro, Renato D. Lópes, Phillip J. Schulte, et al.. (2015). Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease. Circulation. 132(8). 624–632. 166 indexed citations
16.
Mehta, Rajendra H., T. Bruce Ferguson, Renato D. Lópes, et al.. (2011). Saphenous Vein Grafts With Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery. Circulation. 124(3). 280–288. 66 indexed citations
17.
Alexander, John H., Robert W. Emery, Michel Carrier, et al.. (2008). Efficacy and Safety of Pyridoxal 5′-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery. JAMA. 299(15). 1777–1777. 28 indexed citations
18.
Dyke, Christopher K., Steven R. Steinhubl, Neal S. Kleiman, et al.. (2006). First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. Circulation. 114(23). 2490–2497. 166 indexed citations
19.
Williams, Bryan, Olivier F. Bertrand, & John H. Alexander. (2005). Late-Breaking Clinical Trial Abstracts. Circulation. 112(21). 3362–3364. 4 indexed citations
20.
Alexander, John H., David F. Kong, & Warren J. Cantor. (1999). Highlights from the 71st American Heart Association Scientific Sessions: November 8 to 11, 1998. American Heart Journal. 137(3). 555–574. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026